• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织学分级和肿瘤大小减小对乳腺癌患者新辅助化疗后腋窝淋巴结状态的影响。

Histologic Grade and Decrease in Tumor Dimensions Affect Axillary Lymph Node Status after Neoadjuvant Chemotherapy in Breast Cancer Patients.

作者信息

Kim Tae Hee, Kang Doo Kyoung, Kim Ji Young, Han Sehwan, Jung Yongsik

机构信息

Department of Radiology, Ajou University School of Medicine, Suwon, Korea.

Department of Surgery, Ajou University School of Medicine, Suwon, Korea.

出版信息

J Breast Cancer. 2015 Dec;18(4):394-9. doi: 10.4048/jbc.2015.18.4.394. Epub 2015 Dec 23.

DOI:10.4048/jbc.2015.18.4.394
PMID:26770247
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4705092/
Abstract

PURPOSE

The purposes our study was to find out any histologic factors associated with negative conversion of axillary lymph node (ALN) after neoadjuvant chemotherapy (NAC). We also evaluated the association between the decrease in size of primary breast tumor and negative conversion of ALN.

METHODS

From January 2012 to November 2014, we included 133 breast cancer patients who underwent NAC and who had ALN metastases which were confirmed on fine-needle aspiration or core needle biopsy at initial diagnosis. All 133 patients underwent initial magnetic resonance imaging (MRI) at the time of diagnosis and preoperative MRI after completion of NAC. We measured the longest dimension of primary breast cancer on MRI.

RESULTS

Of 133 patients, 39 patients (29%) showed negative conversion of ALN and of these 39 patients, 25 patients (64%) showed pathologic complete remission of primary breast. On univariate analysis, mean percent decrease in longest dimension, estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2 status and histologic grade were significantly associated with the ALN status after NAC (p<0.001, p=0.001, p< 0.001, p=0.001, p=0.002, respectively). On multivariate logistic regression analysis, percent decrease in longest dimension (odds ratio, 1.026; 95% confidence interval [CI], 1.009-1.044) and histologic grade (odds ratio, 3.964; 95% CI, 1.151-13.657) were identified as being independently associated with the ALN status after NAC. The area under the receiver operating characteristic curve was 0.835 with the best cutoff value of 80% decrease in longest dimension. Combination of high histologic grade and more than 80% decrease in longest dimension showed 64% sensitivity and 92% specificity.

CONCLUSION

High histologic grade and more than 80% decrease in primary tumor dimension were associated with negative conversion of ALN after NAC.

摘要

目的

本研究旨在找出与新辅助化疗(NAC)后腋窝淋巴结(ALN)转阴相关的任何组织学因素。我们还评估了原发性乳腺肿瘤大小的减小与ALN转阴之间的关联。

方法

2012年1月至2014年11月,我们纳入了133例接受NAC且在初始诊断时经细针穿刺或粗针活检证实有ALN转移的乳腺癌患者。所有133例患者在诊断时均接受了初始磁共振成像(MRI)检查,并在NAC完成后接受了术前MRI检查。我们在MRI上测量了原发性乳腺癌的最长径。

结果

133例患者中,39例(29%)显示ALN转阴,在这39例患者中,25例(64%)显示原发性乳腺病理完全缓解。单因素分析显示,最长径平均减小百分比、雌激素受体、孕激素受体、人表皮生长因子受体2状态和组织学分级与NAC后的ALN状态显著相关(p分别<0.001、p = 0.001、p<0.001、p = 0.001、p = 0.002)。多因素逻辑回归分析显示,最长径减小百分比(比值比,1.026;95%置信区间[CI],1.009 - 1.044)和组织学分级(比值比,3.964;95%CI,1.151 - 13.657)被确定为与NAC后的ALN状态独立相关。受试者工作特征曲线下面积为0.835,最长径最佳截断值为减小80%。高组织学分级与最长径减小超过80%的组合显示出64%的敏感性和92%的特异性。

结论

高组织学分级和原发性肿瘤径减小超过80%与NAC后ALN转阴相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079a/4705092/06c422ccb8d2/jbc-18-394-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079a/4705092/06c422ccb8d2/jbc-18-394-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079a/4705092/06c422ccb8d2/jbc-18-394-g001.jpg

相似文献

1
Histologic Grade and Decrease in Tumor Dimensions Affect Axillary Lymph Node Status after Neoadjuvant Chemotherapy in Breast Cancer Patients.组织学分级和肿瘤大小减小对乳腺癌患者新辅助化疗后腋窝淋巴结状态的影响。
J Breast Cancer. 2015 Dec;18(4):394-9. doi: 10.4048/jbc.2015.18.4.394. Epub 2015 Dec 23.
2
Evaluation of lymph node status after neoadjuvant chemotherapy in breast cancer patients: comparison of diagnostic performance of ultrasound, MRI and ¹⁸F-FDG PET/CT.乳腺癌患者新辅助化疗后淋巴结状态的评估:超声、MRI和¹⁸F-FDG PET/CT诊断性能的比较
Br J Radiol. 2015 Aug;88(1052):20150143. doi: 10.1259/bjr.20150143.
3
Nomogram for predicting axillary lymph node status after neoadjuvant chemotherapy in breast cancer.预测乳腺癌新辅助化疗后腋窝淋巴结状态的列线图
Transl Cancer Res. 2020 Nov;9(11):7054-7064. doi: 10.21037/tcr-20-2377.
4
Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer: retrospective comparative evaluation of clinically axillary lymph node positive and negative patients, including those with axillary lymph node metastases confirmed by fine needle aspiration.乳腺癌新辅助化疗后前哨淋巴结活检:对临床腋窝淋巴结阳性和阴性患者(包括经细针穿刺确诊有腋窝淋巴结转移的患者)的回顾性比较评估
BMC Cancer. 2016 Oct 18;16(1):808. doi: 10.1186/s12885-016-2829-5.
5
Restaging the axilla after neo-adjuvant chemotherapy for breast cancer: Predictive factors for residual metastatic lymph node disease with negative imaging findings.乳腺癌新辅助化疗后腋窝再分期:阴性影像学发现的残留转移性淋巴结疾病的预测因素。
Breast J. 2019 Mar;25(2):196-201. doi: 10.1111/tbj.13192. Epub 2019 Feb 3.
6
Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer.新辅助化疗后细胞学证实淋巴结阳性乳腺癌的前哨淋巴结活检。
Clin Breast Cancer. 2013 Dec;13(6):471-7. doi: 10.1016/j.clbc.2013.08.014.
7
Can breast MRI predict axillary lymph node metastasis in women undergoing neoadjuvant chemotherapy.乳腺 MRI 能否预测接受新辅助化疗的女性腋窝淋巴结转移。
Ann Surg Oncol. 2010 Jul;17(7):1841-6. doi: 10.1245/s10434-010-0934-2. Epub 2010 Feb 9.
8
Diagnostic performance of breast ultrasonography and MRI in the prediction of lymph node status after neoadjuvant chemotherapy for breast cancer.乳腺癌新辅助化疗后乳腺超声和MRI对淋巴结状态预测的诊断性能
Acta Radiol. 2017 Oct;58(10):1198-1205. doi: 10.1177/0284185117690421. Epub 2017 Mar 28.
9
Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy.新辅助化疗治疗患者术前记录的乳腺癌腋窝淋巴结转移灶根除的发生率及影响
Ann Surg. 1999 Jul;230(1):72-8. doi: 10.1097/00000658-199907000-00011.
10
Factors Associated with Axillary Lymph Node Status in Clinically Node-Negative Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.接受新辅助化疗的临床腋窝淋巴结阴性乳腺癌患者腋窝淋巴结状态的相关因素
Cancers (Basel). 2022 Sep 14;14(18):4451. doi: 10.3390/cancers14184451.

引用本文的文献

1
Modeling the risk of axillary lymph node metastasis after neoadjuvant chemotherapy in breast cancer: A retrospective study.乳腺癌新辅助化疗后腋窝淋巴结转移风险的建模:一项回顾性研究。
Mol Clin Oncol. 2025 Jul 23;23(4):89. doi: 10.3892/mco.2025.2884. eCollection 2025 Oct.
2
Enhanced preoperative prediction of breast lesion pathology, prognostic biomarkers, and molecular subtypes using multiple models diffusion-weighted MR imaging.使用多模型扩散加权磁共振成像增强对乳腺病变病理、预后生物标志物和分子亚型的术前预测。
Sci Rep. 2025 Feb 8;15(1):4704. doi: 10.1038/s41598-024-81713-3.
3
Prediction of pathological complete response of breast cancer patients who received neoadjuvant chemotherapy with a nomogram based on clinicopathologic variables, ultrasound, and MRI.

本文引用的文献

1
Evaluation of lymph node status after neoadjuvant chemotherapy in breast cancer patients: comparison of diagnostic performance of ultrasound, MRI and ¹⁸F-FDG PET/CT.乳腺癌患者新辅助化疗后淋巴结状态的评估:超声、MRI和¹⁸F-FDG PET/CT诊断性能的比较
Br J Radiol. 2015 Aug;88(1052):20150143. doi: 10.1259/bjr.20150143.
2
Axillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance).新辅助化疗后的腋窝超声及其对前哨淋巴结手术的影响:美国外科医师学会肿瘤学组Z1071试验(联盟)的结果
J Clin Oncol. 2015 Oct 20;33(30):3386-93. doi: 10.1200/JCO.2014.57.8401. Epub 2015 Feb 2.
3
基于临床病理变量、超声和 MRI 的列线图预测接受新辅助化疗的乳腺癌患者的病理完全缓解。
Br J Radiol. 2024 Jan 23;97(1153):228-236. doi: 10.1093/bjr/tqad014.
4
Diagnostic performance of MRI for assessing axillary lymph node status after neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.MRI 评估乳腺癌新辅助化疗后腋窝淋巴结状态的诊断性能:系统评价和荟萃分析。
Eur Radiol. 2024 Feb;34(2):930-942. doi: 10.1007/s00330-023-10155-8. Epub 2023 Aug 24.
5
Prediction of Residual Axillary Nodal Metastasis Following Neoadjuvant Chemotherapy for Breast Cancer: Radiomics Analysis Based on Chest Computed Tomography.基于胸部 CT 的放射组学分析预测乳腺癌新辅助化疗后腋窝残留淋巴结转移
Korean J Radiol. 2023 Jun;24(6):498-511. doi: 10.3348/kjr.2022.0731.
6
Clinical and pathological features analysis of invasive breast cancer with microcalcification.伴有微钙化的浸润性乳腺癌的临床和病理特征分析。
Cancer Med. 2023 May;12(10):11351-11362. doi: 10.1002/cam4.5848. Epub 2023 Mar 27.
7
Correlation between histopathological grading and shear-wave elastography in evaluating invasive carcinoma of no special type.在评估非特殊类型浸润性癌中组织病理学分级与剪切波弹性成像的相关性
Exp Ther Med. 2018 Dec;16(6):4700-4706. doi: 10.3892/etm.2018.6790. Epub 2018 Sep 24.
8
Is it always necessary to perform an axillary lymph node dissection after neoadjuvant chemotherapy for breast cancer?乳腺癌新辅助化疗后总是有必要进行腋窝淋巴结清扫吗?
Ann R Coll Surg Engl. 2019 Mar;101(3):186-192. doi: 10.1308/rcsann.2018.0196. Epub 2018 Nov 13.
Noninvasive nodal restaging in clinically node positive breast cancer patients after neoadjuvant systemic therapy: a systematic review.
新辅助全身治疗后临床淋巴结阳性乳腺癌患者的无创淋巴结再分期:一项系统评价
Eur J Radiol. 2015 Jan;84(1):41-47. doi: 10.1016/j.ejrad.2014.09.020. Epub 2014 Oct 13.
4
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.新辅助化疗后前哨淋巴结阳性乳腺癌患者的前哨淋巴结手术:ACOSOG Z1071(Alliance)临床试验。
JAMA. 2013 Oct 9;310(14):1455-61. doi: 10.1001/jama.2013.278932.
5
Imaging response and residual metastatic axillary lymph node disease after neoadjuvant chemotherapy for primary breast cancer.原发性乳腺癌新辅助化疗后的影像学反应和残留转移性腋窝淋巴结疾病。
Ann Surg Oncol. 2013 Oct;20(10):3199-204. doi: 10.1245/s10434-013-3118-z. Epub 2013 Jul 12.
6
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.新辅助化疗前后乳腺癌前哨淋巴结活检(SENTINA):一项前瞻性、多中心队列研究。
Lancet Oncol. 2013 Jun;14(7):609-18. doi: 10.1016/S1470-2045(13)70166-9. Epub 2013 May 15.
7
Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytologically proven node-positive breast cancer at diagnosis.诊断时细胞学证实淋巴结阳性的乳腺癌患者新辅助化疗后前哨淋巴结活检。
Ann Surg Oncol. 2013 Sep;20(9):2858-65. doi: 10.1245/s10434-013-2992-8. Epub 2013 May 5.
8
Patient and tumor characteristics associated with breast cancer recurrence after complete pathological response to neoadjuvant chemotherapy.新辅助化疗完全病理缓解后与乳腺癌复发相关的患者和肿瘤特征。
Breast Cancer Res Treat. 2013 Jan;137(1):195-201. doi: 10.1007/s10549-012-2312-1. Epub 2012 Nov 13.
9
Accuracy and axilla sparing potentials of sentinel lymph node biopsy with methylene blue alone performed before versus after neoadjuvant chemotherapy in breast cancer: a single institution experience.单独使用亚甲蓝行前与新辅助化疗后乳腺癌前哨淋巴结活检的准确性和腋窝保留潜能:单机构经验。
Clin Transl Oncol. 2013 Jan;15(1):79-84. doi: 10.1007/s12094-012-0885-0. Epub 2012 Aug 28.
10
Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.不同内在型乳腺癌亚型新辅助化疗后病理完全缓解对预后的定义和影响。
J Clin Oncol. 2012 May 20;30(15):1796-804. doi: 10.1200/JCO.2011.38.8595. Epub 2012 Apr 16.